Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

2 Apr 2009 11:41

RNS Number : 0038Q
Omega Diagnostics Group PLC
02 April 2009
 



Omega Diagnostics Group Plc 

("Omega")

Trading Update

Omega, the AIM listed medical diagnostics company, announces that revenue for the year ended 31 March 2009 is £5.44m, some 56% ahead of last year's figure (31 March 2008: £3.49m). On a full like for like basis, turnover has increased by 20% combined, and individually across all three trading entities, where the figures in brackets for Genesis Diagnostics and Cambridge Nutritional Sciences represent the full 12-month comparative:

31 March 2009

31 March 2008

% increase

Omega Diagnostics (ODL)

£2.28m

£2.08m

+9.5%

Genesis Diagnostics

£2.51m

£1.07m (£1.90m)

+133.9% (+32.6%)

Cambridge Nutritional Sciences

£0.65m

£0.34m (£0.56m)

+93.9% (+16.5%)

TOTAL

£5.44m

£3.49m (£4.54m)

+55.9% (+20.0%)

ODL has seen growth in most of its regions around the world, particularly in Africa/Middle East and Asian regions. Genesis has seen growth fuelled mainly by the roll-out into a number of territories of its microarray-based Genarrayt™ assay system for food intolerance, where evaluations are on-going which are expected to lead to increased sales of reagent kits going forward. CNS has benefited from launching the Food Detective™ kit into a number of European territories and from an increase in sales from its Foodprint™ laboratory testing service.

Profit before tax (and before share based payments, exceptional costs and amortisation of intangible assets) is expected to be in line with market expectations. 

The outlook for the new financial year is encouraging as we expect to continue to widen the roll-out of the Genarrayt™ system and to launch Food Detective™ into other new markets and we look forward to providing an update on progress when the full year results are announced in early July 2009.

Further enquiries:

Omega Diagnostics Plc

Tel: 01259 763 030

Andrew Shepherd, Chief Executive

Kieron Harbinson, Group Finance Director

www.omegadiagnostics.com

Cenkos Securities plc

Tel: 020 7397 8900

Nick Wells

Andy Roberts

Elizabeth Bowman

Parkgreen Communications Limited

Tel: 020 7933 8787

Paul McManus

Mob: 07980 541 893

paul.mcmanus@parkgreenmedia.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFGGGDGZLGLZM
Date   Source Headline
28th Nov 201412:55 pmRNSCorrection: Director's Dealing
28th Nov 201410:35 amRNSDirector's Dealing
28th Nov 20147:00 amRNSDirector's Dealing
26th Nov 20147:00 amRNSHalf Yearly Report
24th Oct 20147:00 amRNSTrading Update and Notice of Interim Results
28th Aug 201412:39 pmRNSResult of AGM
1st Jul 20147:00 amRNSmHealth partnership in Sub-Saharan Africa
23rd Jun 20147:00 amRNSFinal Results
14th Apr 20147:00 amRNSTrading Update and Notice of Results
24th Mar 20144:34 pmRNSDirector/PDMR Shareholding
5th Mar 20142:38 pmRNSDirector/PDMR Shareholding
4th Mar 20143:07 pmRNSHolding(s) in Company
3rd Mar 201411:30 amRNSHolding(s) in Company
28th Feb 201412:42 pmRNSHolding(s) in Company
25th Feb 201411:38 amRNSGrant of Options
25th Feb 201410:06 amRNSCD4 - Grant of ARIPO Patent
24th Feb 20147:00 amRNSAllergy Development Update
24th Feb 20147:00 amRNSCD4 - UNITAID Grant Funding
21st Feb 20142:55 pmRNSHolding(s) in Company
13th Feb 20147:00 amRNSSuccessful completion of CD4 Technology Transfer
20th Dec 20137:00 amRNSCD4 Update
17th Dec 201310:27 amRNSHolding(s) in Company
27th Nov 20137:00 amRNSInterim Results
31st Oct 20137:00 amRNSCD4 Update
17th Oct 20137:00 amRNSTrading Update and Notice of Interim Results
26th Sep 20137:00 amRNSCD4 Update
28th Aug 201311:59 amRNSResult of AGM
17th Jul 201312:10 pmRNSHolding(s) in Company
15th Jul 201311:58 amRNSDirector/PDMR Shareholding
4th Jul 201311:22 amRNSGrant of Options
3rd Jul 20132:21 pmRNSHolding(s) in Company
1st Jul 20137:00 amRNSFinal Results
21st Jun 20137:00 amRNSAllergy Development Update
17th Jun 201310:03 amRNSHolding(s) in Company
10th Jun 201312:18 pmRNSResult of GM
24th May 20137:00 amRNSFundraising to raise £4 million
23rd Apr 20137:00 amRNSGrant of US Patent
22nd Apr 20137:00 amRNSDirectorate Change
10th Apr 20137:00 amRNSTrading Update and Notice of Results
10th Apr 20137:00 amRNSDistribution Agreement
4th Mar 20137:00 amRNSChange of Adviser
17th Dec 20127:00 amRNSChina approves Registration of Food Detective
13th Dec 20127:00 amRNSBanking Facilities increased
3rd Dec 20124:17 pmRNSHolding(s) in Company
21st Nov 20127:00 amRNSHalf Yearly Report
19th Nov 20127:00 amRNSGrant funding award
15th Oct 20127:00 amRNSAgreement with Super Religare Laboratories
15th Oct 20127:00 amRNSTrading Update & Notice of Results
28th Aug 201211:49 amRNSResult of AGM
23rd Jul 20127:00 amRNSPublication of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.